Reiner Laus
Division President Cancer Vaccines, Executive Vice
President
Mr. Laus joined Bavarian Nordic in 2005 as CEO of BN
ImmunoTherapeutics, Inc. In 2008 he was appointed Executive Vice
President. Prior to joining Bavarian Nordic, he was Vice President
of Research and Development at Dendreon Corporation in Seattle,
Washington where he was responsible for discovery, pre-clinical and
development functions. Mr. Laus received his M.D. from the
University of Kiel. Mr. Laus is member of the Board of Directors of
CG Therapeutics Inc. Mr. Laus is a German national, born in
1960.
